User profiles for F. Kapczinski
Kapczinski FProfessor UFRGS, HCPA, Emeritus McMaster University Verified email at hcpa.edu.br Cited by 48487 |
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
There is now strong evidence of progressive neuropathological processes in bipolar disorder
(BD). On this basis, the current understanding of the neurobiology of BD has shifted from …
(BD). On this basis, the current understanding of the neurobiology of BD has shifted from …
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
…, RM Hirschfeld, F Kapczinski… - American Journal of …, 2013 - Am Psychiatric Assoc
Objective The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …
Allostatic load in bipolar disorder: implications for pathophysiology and treatment
Current literature on the effects of chronic stress in general health converges to the concept
of allostatic load (AL). AL is the bodily ‘wear and tear’ that emerges with sustained allostatic …
of allostatic load (AL). AL is the bodily ‘wear and tear’ that emerges with sustained allostatic …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …
The Canadian Network for Mood and Anxiety Treatments ( CANMAT ) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
[HTML][HTML] Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder
…, W Van Riel, JL Ayuso-Mateos, F Kapczinski… - Clinical Practice and …, 2007 - Springer
Background Numerous studies have documented high rates of functional impairment among
bipolar disorder (BD) patients, even during phases of remission. However, the majority of …
bipolar disorder (BD) patients, even during phases of remission. However, the majority of …
[HTML][HTML] Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients
…, BS De Martinis, F Kapczinski… - …, 2011 - nature.com
… on anxiety (F 2,35 =1.4; p=0.27), sedation (F 2,35 =0.4; p=0.70), cognitive impairment (…
a significant effect of phases (F 3.3,110.2 =8.1; p<0.001) and phases by group interaction (…
a significant effect of phases (F 3.3,110.2 =8.1; p<0.001) and phases by group interaction (…
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for …
The Canadian Network for Mood and Anxiety Treatments (CANMAT) published guidelines
for the management of bipolar disorder in 2005, with a 2007 update. This second update, in …
for the management of bipolar disorder in 2005, with a 2007 update. This second update, in …
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
…, WA Nolen, E Vieta, F Kapczinski… - Bipolar …, 2009 - Wiley Online Library
Objectives: Via an international panel of experts, this paper attempts to document, review,
interpret, and propose operational definitions used to describe the course of bipolar disorders …
interpret, and propose operational definitions used to describe the course of bipolar disorders …
Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression
Background Studies investigating inflammatory markers in post-traumatic stress disorder (PTSD)
have yielded mixed results. The aim of our study was to compare concentrations of …
have yielded mixed results. The aim of our study was to compare concentrations of …
Oxidative stress markers in bipolar disorder: a meta-analysis
… Kapczinski has been an investigator in clinical trials sponsored by CNPq, the Canadian
Institutes of Health Research, Stanley Foundation and Servier. He has worked as a consultant/…
Institutes of Health Research, Stanley Foundation and Servier. He has worked as a consultant/…